These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 2410106)
1. Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection. Sarngadharan MG; diMarzo Veronese F; Lee S; Gallo RC Cancer Res; 1985 Sep; 45(9 Suppl):4574s-4577s. PubMed ID: 2410106 [TBL] [Abstract][Full Text] [Related]
2. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972). Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697 [TBL] [Abstract][Full Text] [Related]
4. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings. Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682 [TBL] [Abstract][Full Text] [Related]
5. Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III). Fischinger PJ; Robey WG; Koprowski H; Gallo RC; Bolognesi DP Cancer Res; 1985 Sep; 45(9 Suppl):4694s-4699s. PubMed ID: 2410115 [TBL] [Abstract][Full Text] [Related]
6. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168 [TBL] [Abstract][Full Text] [Related]
7. Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24. Casey JM; Kim Y; Andersen PR; Watson KF; Fox JL; Devare SG J Virol; 1985 Aug; 55(2):417-23. PubMed ID: 2410630 [TBL] [Abstract][Full Text] [Related]
8. HTLV and immunosuppression. Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649 [TBL] [Abstract][Full Text] [Related]
9. Clinical and immunological findings in HTLV-III infection. Krohn KJ; Antonen J; Valle SL; Kazakevicius R; Saxinger C; Gallo RC; Ranki A Cancer Res; 1985 Sep; 45(9 Suppl):4612s-4615s. PubMed ID: 2990694 [TBL] [Abstract][Full Text] [Related]
10. Immunological properties of the Gag protein p24 of the acquired immunodeficiency syndrome retrovirus (human T-cell leukemia virus type III). Sarngadharan MG; Bruch L; Popovic M; Gallo RC Proc Natl Acad Sci U S A; 1985 May; 82(10):3481-4. PubMed ID: 2582414 [TBL] [Abstract][Full Text] [Related]
11. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome. Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287 [TBL] [Abstract][Full Text] [Related]
12. Expression of HTLV-I in serum of HTLV-I-related subjects and the early detection of overt ATL in HTLV-I carriers. Ishibashi K; Hanada S; Hashimoto S J Immunol; 1987 Sep; 139(5):1509-13. PubMed ID: 2442248 [TBL] [Abstract][Full Text] [Related]
14. Human T-cell lymphotropic virus type III associated disorders. The spectrum in the heterosexual population. Gill PS; Levine AM; Meyer PR; Aguilar SL; Rarick M; Parker JW; Rasheed S Arch Intern Med; 1986 Aug; 146(8):1501-4. PubMed ID: 3015064 [TBL] [Abstract][Full Text] [Related]
15. Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS. Schüpbach J; Haller O; Vogt M; Lüthy R; Joller H; Oelz O; Popovic M; Sarngadharan MG; Gallo RC N Engl J Med; 1985 Jan; 312(5):265-70. PubMed ID: 2981407 [TBL] [Abstract][Full Text] [Related]
16. [Prevalence of antibodies against HTLV-III in various regions in Switzerland]. Schüpbach J; Vogt M; Bhushan R; Lüthy R; Haller O; Joller H; Ferber T; Büchner S; Schuppli R; Schädelin J Schweiz Med Wochenschr; 1985 Jul; 115(30):1048-54. PubMed ID: 2994208 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies reactive with human T cell lymphotropic virusI (HTLVI) p19 internal core protein: cross-reactivity with normal tissues and differential reactivity with HTLV types I and II. Palker TJ; Scearce RM; Ho W; Copeland TD; Oroszlan S; Popovic M; Haynes BF J Immunol; 1985 Jul; 135(1):247-54. PubMed ID: 2987346 [TBL] [Abstract][Full Text] [Related]
18. Human retroviral env and gag polypeptides: serologic assays to measure infection. Kanner SB; Cheng-Mayer C; Geffin RB; Parks WP; Beltz GA; Arthur LO; Samuel KP; Papas TS J Immunol; 1986 Jul; 137(2):674-8. PubMed ID: 3014000 [TBL] [Abstract][Full Text] [Related]
19. Sera of adult T-cell leukemia patients and carriers of human T-cell leukemia virus type I in Japan do not cross-react with antigens of lymphadenopathy virus. Katamine S; Sugiyama H; Moriuchi R; Miyamoto T; Hino S Jpn J Cancer Res; 1985 Apr; 76(4):245-8. PubMed ID: 2989058 [TBL] [Abstract][Full Text] [Related]
20. [Properties and transmission of the AIDS virus]. Laufs R Hautarzt; 1986 May; 37(5):245-9. PubMed ID: 3015839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]